» Articles » PMID: 35867303

Development and Validation of a Meta-learning-based Multi-modal Deep Learning Algorithm for Detection of Peritoneal Metastasis

Overview
Publisher Springer
Date 2022 Jul 22
PMID 35867303
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The existing medical imaging tools have a detection accuracy of 97% for peritoneal metastasis(PM) bigger than 0.5 cm, but only 29% for that smaller than 0.5 cm, the early detection of PM is still a difficult problem. This study is aiming at constructing a deep convolution neural network classifier based on meta-learning to predict PM.

Method: Peritoneal metastases are delineated on enhanced CT. The model is trained based on meta-learning, and features are extracted using multi-modal deep Convolutional Neural Network(CNN) with enhanced CT to classify PM. Besides, we evaluate the performance on the test dataset, and compare it with other PM prediction algorithm.

Results: The training datasets are consisted of 9574 images from 43 patients with PM and 67 patients without PM. The testing datasets are consisted of 1834 images from 21 testing patients. To increase the accuracy of the prediction, we combine the multi-modal inputs of plain scan phase, portal venous phase and arterial phase to build a meta-learning-based multi-modal PM predictor. The classifier shows an accuracy of 87.5% with Area Under Curve(AUC) of 0.877, sensitivity of 73.4%, specificity of 95.2% on the testing datasets. The performance is superior to routine PM classify based on logistic regression (AUC: 0.795), a deep learning method named ResNet3D (AUC: 0.827), and a domain generalization (DG) method named MADDG (AUC: 0.834).

Conclusions: we proposed a novel training strategy based on meta-learning to improve the model's robustness to "unseen" samples. The experiments shows that our meta-learning-based multi-modal PM predicting classifier obtain more competitive results in synchronous PM prediction compared to existing algorithms and the model's improvements of generalization ability even with limited data.

Citing Articles

Multimodal deep learning approaches for precision oncology: a comprehensive review.

Yang H, Yang M, Chen J, Yao G, Zou Q, Jia L Brief Bioinform. 2025; 26(1).

PMID: 39757116 PMC: 11700660. DOI: 10.1093/bib/bbae699.


Using artificial intelligence and statistics for managing peritoneal metastases from gastrointestinal cancers.

Wojtulewski A, Sikora A, Dineen S, Raoof M, Karolak A Brief Funct Genomics. 2024; 24.

PMID: 39736152 PMC: 11735730. DOI: 10.1093/bfgp/elae049.


A radiomics-boosted deep-learning for risk assessment of synchronous peritoneal metastasis in colorectal cancer.

Zhang D, Zheng B, Xu L, Wu Y, Shen C, Bao S Insights Imaging. 2024; 15(1):150.

PMID: 38886244 PMC: 11183032. DOI: 10.1186/s13244-024-01733-5.


Application of artificial intelligence in the diagnosis, treatment, and recurrence prediction of peritoneal carcinomatosis.

Wei G, Zhou Y, Li Z, Qiu M Heliyon. 2024; 10(7):e29249.

PMID: 38601686 PMC: 11004411. DOI: 10.1016/j.heliyon.2024.e29249.


Imaging Evaluation of Peritoneal Metastasis: Current and Promising Techniques.

Fu C, Zhang B, Guo T, Li J Korean J Radiol. 2024; 25(1):86-102.

PMID: 38184772 PMC: 10788608. DOI: 10.3348/kjr.2023.0840.

References
1.
Franko J, Shi Q, Goldman C, Pockaj B, Nelson G, Goldberg R . Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2011; 30(3):263-7. PMC: 3269953. DOI: 10.1200/JCO.2011.37.1039. View

2.
Thomassen I, van Gestel Y, van Ramshorst B, Luyer M, Bosscha K, Nienhuijs S . Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2013; 134(3):622-8. DOI: 10.1002/ijc.28373. View

3.
Lemmens V, Klaver Y, Verwaal V, Rutten H, Coebergh J, de Hingh I . Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer. 2010; 128(11):2717-25. DOI: 10.1002/ijc.25596. View

4.
Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A . Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2012; 99(5):699-705. DOI: 10.1002/bjs.8679. View

5.
Shida D, Tsukamoto S, Ochiai H, Kanemitsu Y . Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol. 2017; 25(1):173-178. DOI: 10.1245/s10434-017-6133-7. View